Crohn’s Disease Study
Crohn’s Disease doesn’t have to sit first chair.
If you are living with Crohn’s, our clinical research study may be for you. Our team of medical professionals is evaluating an oral investigational drug called filgotinib to see if it reduces the signs and symptoms of Crohn’s disease by lowering the immune response that causes inflammation in the digestive system.
Qualified participants may:
- Try an oral investigational drug to see if it reduces the signs and symptoms of Crohn’s disease
- Receive study drug and monitoring from a local study doctor at no cost
- Be eligible to participate in a long-term extension study
- Receive reimbursement for study-related travel expenses
If you have moderate to severely active Crohn’s Disease and are between 18 to 75 years of age, you may qualify for our current study. Please fill out the form below or call us at (423) 698-4584 for more information.